	Dysregulation of circ-SMARCA5, circ-RHOT1, and HNF1A and the association of HNF1A polymorphisms with hepatocellular carcinoma. Mol Biol Rep Ibrahim BA, Elsayed BS, Gendia MA, Moustafa M, El Desoky AMZ. PMID: 42663735 [PubMed - indexed for MEDLINE]
	Proof-of-Concept Study of Hyperpolarized [1-(13)C]Pyruvate MRI in Participants with Hepatocellular Carcinoma. Radiol Imaging Cancer Kjærgaard U, Bøgh N, Aastrup M, Kristensen MH, Christensen NV, Sivesgaard K, Ringgaard S, Bonde Bertelsen L, Hansen ESS, Grønbæk H, Villadsen GE, Laustsen C. PMID: 42663532 [PubMed - indexed for MEDLINE]
	Diagnostic Yield and Cost of Morphology-Guided Immunohistochemistry in Liver Tumors. Asian Pac J Cancer Prev Charoenlap C, Arunsawat P, Prateepchaiboon T, Chienwichai K, Chang A. PMID: 42663230 [PubMed - indexed for MEDLINE]
	Diagnostic and Prognostic Values of Microfibrillar-Associated Protein 5 and Heat Shock Protein 90 Alpha in Patients with HCV-Induced Hepatocellular Carcinoma Undergoing Locoregional Therapy. Asian Pac J Cancer Prev Mosbbah RAE, Abd El-Maksoud M, Abo El-Khair SM, Shiha U, El-Eraky A, Shabana W. PMID: 42663215 [PubMed - indexed for MEDLINE]
	Dysregulated Interleukin Expression in Iraqi Hepatocellular Carcinoma: Diagnostic and Prognostic Implications. Asian Pac J Cancer Prev Essa AM, Esaa SM, Hoidy WH, Al-Saadi MH. PMID: 42663209 [PubMed - indexed for MEDLINE]
	Development and Internal Validation of the SPR-HCC Score System: A Prognostic Tool for Survival Prediction in Hepatocellular Carcinoma in a Resource-Limited Setting. Asian Pac J Cancer Prev Neesanun S, Patumanond J. PMID: 42663200 [PubMed - indexed for MEDLINE]
	Impact of PD-1 Inhibitor Timing Relative to Locoregional Therapy on Outcomes in uHCC Treated With Lenvatinib-Based Triple Therapy. Liver Int He J, Chen J, Yu B, Wei F, Liu W, Huang P, Wu S, You X, Chen Z, Lin Z, Guo W, Zhuang S, Chen Y, Chen Z. PMID: 42661423 [PubMed - indexed for MEDLINE]
	Integrated bioinformatic evaluation unveils a cellular senescence gene signature as a poor prognostic factor in hepatocellular carcinoma. Clin Exp Med Lu S, Ma J, Wang X, Zhang L, Lu J, Hu J. PMID: 42661129 [PubMed - indexed for MEDLINE]
	Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment, and follow-up of patients with hepatocellular carcinoma. ESMO Open Tan CK, Vogel A, Wong YF, Ho GF, Zhou J, Atmakusuma TD, Kulkarni P, Kodama T, Chon HJ, Bello M, Yong WP, Hsu C, Korphaisarn K, Tanasanvimon S, Chen SC, Lee SY, Sebastian MR, Huh SJ, Morizane C, Tiwari P, Kalista KF, Qin S, Smyth EC, Lim E, Hou TC, Pentheroudakis G, Shan CW, André F, Muthukkumaran T, Ducreux M. PMID: 42660571 [PubMed - indexed for MEDLINE]
	MRI of Hepatocellular Carcinoma: Cross-regional Perspectives on Trends and Opportunities. Radiographics Tan CH, Jiang H, Wang YC, Low HM, Welle C, Zhou S, Brancatelli G, Venkatesh SK, Lee JM. PMID: 42658729 [PubMed - indexed for MEDLINE]
	Role of Interventional Oncology in the Management of Neuroendocrine Tumors: 2026 Update. Curr Oncol Rep DePietro DM, Soulen MC. PMID: 42658297 [PubMed - indexed for MEDLINE]
	Treatment Adaptation to Surgical Timing in Pediatric Hepatoblastoma: A 19-Year Single-Center Experience With Resection and Liver Transplantation. Pediatr Transplant Pellegrinelli C, Cavalleri L, Bravi M, Marra P, Valle C, Licini L, Pinelli D, Provenzi M, Sironi S, D'Antiga L. PMID: 42657680 [PubMed - indexed for MEDLINE]
	Factors Affecting Temporal Changes in Ablated Liver Volume After Radiofrequency Ablation for Hepatocellular Carcinoma Evaluated by Three-Dimensional Volumetric Computed Tomography. Tomography Higashi M, Tanabe M, Fujii Y, Furutani H, Ishii J, Takemura Y, Tanabe N, Saeki I, Takami T, Ito K. PMID: 42646914 [PubMed - indexed for MEDLINE]
	The Evolving Role of Immunotherapy in the Treatment with Curative Purpose of Early, Intermediate and Advanced Stage Hepatocellular Carcinoma. Curr Oncol Karampa AD, Goussia A, Baltagiannis EG, Anastasopoulos NT, Christodoulou DK, Glantzounis GK. PMID: 42645397 [PubMed - indexed for MEDLINE]
	Pathological and Perioperative Outcomes of Conversion Hepatectomy After Contemporary Combination Downstaging for Initially Unresectable Hepatocellular Carcinoma: A Systematic Review. Curr Oncol Craciun C, Stanga L, Dejeu D, Davidoiu AM, Ilie AC, Mazilu PO, Craciun L, Pantea S. PMID: 42645358 [PubMed - indexed for MEDLINE]
	A Meta-Analysis of Radiomics-Based Models for Preoperative Assessment of Ki-67 Status in Hepatocellular Carcinoma. J Vis Exp Jia Y, Yu B, Ding L, Li X, Ru Y, Sun H, Song D, Huang C, Zhan J, Yin B, Li D. PMID: 42644535 [PubMed - indexed for MEDLINE]
	Integrating Abnormal Prothrombin (PIVKA-II), Alpha-Fetoprotein, and Routine Clinical Variables for Early Detection of Hepatocellular Carcinoma. J Vis Exp Shou M, Shen R, Xiang G, Wu Y, Xia Q. PMID: 42644494 [PubMed - indexed for MEDLINE]
	Temporal Differentiation of Nonperipheral Washout Refines Prognostic Stratification in HCC. Liver Int Wu Y, Pan J, Yang T, Wei H, Wufuer G, Xia T, Wu Y, Zhang Y, Sun HC, Ju S, Chen F, Ronot M, Song B, Jiang H, Wang Y. PMID: 42642962 [PubMed - indexed for MEDLINE]
	Surgical resection of the primary tumor improves survival in patients with pancreatic neuroendocrine tumors associated with liver metastases: a meta-analysis. Cir Cir Zhu J, Zhang Y, Wang W. PMID: 42641178 [PubMed - indexed for MEDLINE]
	Noninvasive molecular imaging signatures of histopathological growth patterns in colorectal cancer liver metastases. Clin Exp Metastasis Vierasu I, Sclafani F, Van Laethem JL, Delbart W, Doumont G, Bohlok A, Donckier V, Flamen P. PMID: 42640498 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 77297

Page 1 of 3865



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy